02/18/2026 | Press release | Distributed by Public on 02/18/2026 11:48
February 18, 2026- Spring House, PA
Governor Josh Shapiro and Pennsylvania Department of Community & Economic Development (DCED) Secretary Rick Siger announced the Commonwealth has secured over $1 billion in private-sector investment from global health care company Johnson & Johnson to build a next generation cell therapy manufacturing facility in Montgomery County. Supported by a $41.5 million state investment, this expansion project will create more than 500 new jobs over the next twelve years and continue growing Pennsylvania's robust life sciences industry. The project also helps retain 5,885 full-time jobs statewide.
Johnson & Johnson is constructing this state-of-the-art cell therapy manufacturing facility in Lower Gwynedd Township, Montgomery County. The facility will be operated by its subsidiary Janssen Biotech and will directly support the production of medicines for cancer, immune-mediated, and neurological diseases.
"Pennsylvania is a powerhouse for innovation and manufacturing in the life sciences," said Governor Shapiro. "Just a few years ago we weren't even on the field - but today we're competing and winning. We've done it by creating the first economic development plan for Pennsylvania in 2 decades, and following through on it by cutting red tape, making strategic investments in key industries like the life sciences, and strengthening our workforce. That's why companies like Johnson & Johnson are choosing to double down on their investments here in our Commonwealth - because they know we've got the strategy, the workforce, and the speed they need to succeed."
Speaker List:
Joaquin Duato, CEO, Johnson & Johnson
Governor Josh Shapiro
Secretary Rick Siger, PA Department of Community and Economic Development
Commissioner Jamila Winder, Montgomery County Board of Commissioners
Rob Bair, President, Pennsylvania Building Trades
Chris Molineaux, President & CEO, Life Sciences PA